A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Go Back to All Clinical Trials

A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Brief description of study

The purpose of this patient registry is to observe, characterize, and capture real-world data from patients with Group 3 pulmonary hypertension associated with interstitial lung disease (PH-ILD). Group 3 pulmonary hypertension (PH), defined as PH associated with chronic lung disease or hypoxia, is associated with higher morbidity, mortality, and medical costs than similar patients without PH (Barberà 2015). Past registries focus solely on PH or chronic lung disease individually and lack clinically relevant data of the alternate group, making it necessary for a combined group registry.

Clinical Study Identifier: s24-00870

Principal Investigator: Roxana Sulica.

Other Investigators: Rebecca A Fenton, Frank E Cefali.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies